A review of generic preference-based measures of health-related quality of life in visual disorders
- PMID: 22264979
- PMCID: PMC3268858
- DOI: 10.1016/j.jval.2011.08.002
A review of generic preference-based measures of health-related quality of life in visual disorders
Abstract
Objective: This review examines generic preference-based measures and their ability to reflect health-related quality of life in patients with visual disorders.
Methods: A systematic search was undertaken to identify clinical studies of patients with visual disorders where health state utility values were measured and reported. Data were extracted to assess the validity and responsiveness of the measures. A narrative synthesis of the data was undertaken due to the heterogeneity between different studies.
Results: There was considerable heterogeneity in the 31 studies identified in terms of patient characteristics, visual disorders, and outcomes reported. Vision loss was associated with a reduction in scores across the preference-based measure, but the evidence on validity and responsiveness was mixed. The EQ-5D health-related assessment instrument's performance differed according to condition, with poor performance in age-related macular degeneration (AMD) and diabetic retinopathy. The more limited evidence on the HUI-3 instrument found it performed best in differentiating between severity groups of patients with glaucoma, AMD, cataracts, and diabetic retinopathy. One study reported data on the SF-6D instrument and showed it was able to differentiate between patients with AMD.
Conclusions: The performance of the EQ-5D in visual disorders was mixed. The HUI-3 seemed to perform better in some conditions, but the evidence on this and SF-6D is limited. More head to head comparisons of these three measures are required. The new five-level version of EQ-5D may do better at the milder end of visual function.
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Generic Preference-based Measures for Low Back Pain: Which of Them Should Be Used?Spine (Phila Pa 1976). 2016 Mar;41(6):E364-74. doi: 10.1097/BRS.0000000000001247. Spine (Phila Pa 1976). 2016. PMID: 26583478 Free PMC article. Review.
-
An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment.Qual Life Res. 2013 Dec;22(10):2813-28. doi: 10.1007/s11136-013-0417-6. Epub 2013 May 26. Qual Life Res. 2013. PMID: 23709096 Free PMC article. Review.
-
How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review.Value Health. 2011 Sep-Oct;14(6):907-20. doi: 10.1016/j.jval.2011.04.006. Epub 2011 Jul 28. Value Health. 2011. PMID: 21914513 Free PMC article. Review.
-
A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.Clin Exp Rheumatol. 2011 Jul-Aug;29(4):661-71. Epub 2011 Aug 31. Clin Exp Rheumatol. 2011. PMID: 21813061
-
Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.Pharmacoeconomics. 2011 Aug;29(8):719-30. doi: 10.2165/11588360-000000000-00000. Pharmacoeconomics. 2011. PMID: 21635017
Cited by
-
Measurement properties of the EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease.Eur J Health Econ. 2024 Mar 12. doi: 10.1007/s10198-024-01682-2. Online ahead of print. Eur J Health Econ. 2024. PMID: 38472723
-
Cost-Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis.Pharmacoecon Open. 2024 May;8(3):445-457. doi: 10.1007/s41669-023-00465-4. Epub 2024 Mar 4. Pharmacoecon Open. 2024. PMID: 38438829 Free PMC article.
-
Assessing health-related quality of life of people with diabetes in Nigeria using the EQ-5D-5L: a cross-sectional study.Sci Rep. 2023 Dec 18;13(1):22536. doi: 10.1038/s41598-023-49322-8. Sci Rep. 2023. PMID: 38110447 Free PMC article.
-
Psychometric properties and comparison of four health utility approaches among myopia patients in China.Health Qual Life Outcomes. 2023 Jul 4;21(1):66. doi: 10.1186/s12955-023-02150-w. Health Qual Life Outcomes. 2023. PMID: 37403059 Free PMC article.
-
Predictors of problems reported on the EQ-5D-3L dimensions among people with impaired vision in northern Portugal.Health Qual Life Outcomes. 2022 Sep 6;20(1):132. doi: 10.1186/s12955-022-02043-4. Health Qual Life Outcomes. 2022. PMID: 36068600 Free PMC article.
References
-
- Torrance G.W. Measurement of health state utilities for economic appraisal: a review. J Health Econ. 1986;5:1–30. - PubMed
-
- Longworth L., Bryan S. An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ. 2003;12:1061–1067. - PubMed
-
- Brazier J., Roberts J., Tsuchiya A., Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 2004;13:873–884. - PubMed
-
- O'Brien B.J., Spath M., Blackhouse G. A view from the bridge: agreement between the SF 6D utility algorithm and the Health Utilities Index. Health Econ. 2003;12:975–981. - PubMed
-
- Browne J., Jamieson L., Lewsey J. Patient Reported Outcome Measures (PROMs) in elective surgery: report to the Department of Health. Health Services Research Unit, London School of Hygiene & Tropical Medicine & Clinical Effectiveness Unit, Royal College of Surgeons of England; London: 2007.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical